VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,420,913 | -62.4% | 151,161 | -1.0% | 0.00% | -60.0% |
| Q2 2023 | $3,777,229 | +9.6% | 152,677 | +2.3% | 0.01% | 0.0% |
| Q1 2023 | $3,446,460 | -10.2% | 149,262 | -3.1% | 0.01% | -16.7% |
| Q4 2022 | $3,838,506 | +28.8% | 154,095 | +0.4% | 0.01% | +20.0% |
| Q3 2022 | $2,980,000 | -23.8% | 153,460 | -0.4% | 0.01% | -16.7% |
| Q2 2022 | $3,911,000 | -2.0% | 154,018 | +1.6% | 0.01% | +20.0% |
| Q1 2022 | $3,990,000 | -35.8% | 151,535 | +1.7% | 0.01% | -28.6% |
| Q4 2021 | $6,214,000 | +1401.0% | 149,025 | +1501.9% | 0.01% | +600.0% |
| Q3 2021 | $414,000 | – | 9,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |